Medicine & Life Sciences
lysophosphatidic acid
100%
Lysophosphatidic Acid Receptors
75%
Ovarian Neoplasms
47%
Neoplasms
46%
Breast Neoplasms
37%
Protein Array Analysis
33%
Glycogen Synthase Kinase 3
26%
Apoptosis
25%
Mutation
25%
Growth
24%
Phosphorylation
24%
Phosphatidylinositol 3-Kinase
23%
RNA Editing
21%
Proteins
19%
Neoplasm Metastasis
18%
Lysophospholipids
18%
Proteomics
18%
ErbB Receptors
17%
Endometrial Neoplasms
15%
Genes
14%
Carrier Proteins
14%
Adenocarcinoma
14%
Sodium-Glucose Transporter 1
14%
Intercellular Signaling Peptides and Proteins
13%
Phosphotransferases
13%
Cell Line
13%
Cell Survival
13%
Mitogen-Activated Protein Kinases
12%
DNA Repair
12%
Inosine
12%
Prostatic Neoplasms
12%
DNA
12%
Anoikis
12%
MicroRNAs
11%
Cell Proliferation
11%
Catenins
11%
Symporters
11%
Therapeutics
11%
Trastuzumab
11%
Messenger RNA
11%
Phosphatidic Acids
11%
ribosomal protein L39
10%
Stromal Cells
10%
Fibroblasts
10%
G-Protein-Coupled Receptors
9%
Heterografts
9%
Extracellular Signal-Regulated MAP Kinases
9%
Cisplatin
9%
Cell Death
9%
Small Interfering RNA
9%
Adenosine
9%
Androgen Receptors
9%
Pancreatic Neoplasms
9%
PX-866
8%
Pancreatitis
8%
Mitogen-Activated Protein Kinase Kinases
8%
Prostate
8%
High-Throughput Nucleotide Sequencing
8%
Transcription Factor AP-1
8%
Tretinoin
7%
Follistatin-Related Proteins
7%
Carcinogenesis
7%
RNA Stability
7%
Carcinoma
7%
Non-Small Cell Lung Carcinoma
7%
DNA Damage
7%
PTEN Phosphohydrolase
7%
Cyclin C
7%
Phosphatidylinositol 3-Kinases
7%
Cyclic GMP-Dependent Protein Kinase Type I
7%
immune RNA
7%
Serine
7%
Biomarkers
7%
perifosine
7%
Melanoma
6%
Y-Box-Binding Protein 1
6%
entinostat
6%
tetraethylpyrazine
6%
Protein Stability
6%
Breast
6%
Recombinational DNA Repair
6%
Tripartite Motif Proteins
6%
Drug Therapy
6%
Survival
6%
Antibodies
6%
vasodilator-stimulated phosphoprotein
6%
Trypsinogen
6%
Lipidomics
6%
sphingosine 1-phosphate
6%
Transcription Factors
6%
STAT3 Transcription Factor
6%
Amphiregulin
6%
Cell Movement
6%
Neoplasm Genes
6%
Genomics
6%
Small Nuclear RNA
6%
Ovarian Epithelial Carcinoma
6%
Follistatin
6%
Proliferating Cell Nuclear Antigen
6%
In Vitro Techniques
5%